Rapid elevation of serum neuron specific enolase (NSE), pro-gastrin-releasing peptidpro-GRP (pro-GRP), and disease stage are recommended as tumor markers and risk factors for early prediction of adenocarcinoma transformation to SCLC (7, 22–24). Here, ENO2 is linked to adenocarcinoma.